Toxic Element Contamination of Natural Health Products and Pharmaceutical Preparations

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Genuis, Stephen J ^a   Schwalfenberg, Gerry ^a   Siy, Anna Kristen J ^a   Rodushkin, Ilya ^b,c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b LULEÅ UNIVERSITY OF TECHNOLOGY   (Sweden)

^c Sweden   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM; ANTIMONY; ARSENIC; AYURVEDIC DRUG; BARIUM; CADMIUM; CESIUM; CHINESE DRUG; HERBACEOUS AGENT; LEAD; MERCURY; NATURAL PRODUCT; PRENATAL FORMULA; THALLIUM; TIN;

ALTERNATIVE MEDICINE; ARTICLE; BATCH PROCESS; DRUG CONTAMINATION; DRUG CONTROL; DRUG SAFETY; GENERAL PRACTITIONER; PRESCRIPTION; TOXICITY TESTING;

ALBERTA; ARSENIC; BIOLOGICAL AGENTS; CADMIUM; COMPLEMENTARY THERAPIES; DIETARY SUPPLEMENTS; DRUG CONTAMINATION; HUMANS; LEAD; MEDICINE, CHINESE TRADITIONAL; MERCURY; METALS; ONTARIO; PATIENT SAFETY; VITAMINS;

EID: 84869848861     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049676     Document Type: Article

References (114)

1. Landrigan CP, Parry GJ, Bones CB, Hackbarth AD, Goldmann DA, et al. (2010) Temporal trends in rates of patient harm resulting from medical care. The New England journal of medicine 363: 2124-2134.
2. Institute of Medicine (2000) To Err is Human: Building a Safer Health System. Washington D.C.: National Academy Press.
3. Moore TJ, Weiss SR, Kaplan S, Blaisdell CJ, (2002) Reported adverse drug events in infants and children under 2 years of age. Pediatrics 110: e53.
4. Starfield B, (2000) Is US health really the best in the world? JAMA 284: 483-485.
5. Weingart SN, Iezzoni LI, (2003) Looking for medical injuries where the light is bright. JAMA 290: 1917-1919.
6. Zhan C, Miller MR, (2003) Excess length of stay, charges, and mortality attributable to medical injuries during hospitalization. JAMA 290: 1868-1874.
7. McGavock H, (2004) Prescription-related illness-a scandalous pandemic. J Eval Clin Pract 10: 491-497.
8. Onder G, Pedone C, Landi F, Cesari M, Della Vedova C, et al. (2002) Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). J Am Geriatr Soc 50: 1962-1968.
9. Juntti-Patinen L, Neuvonen PJ, (2002) Drug-related deaths in a university central hospital. Eur J Clin Pharmacol 58: 479-482.
10. Thomas EJ, Brennan TA, (2000) Incidence and types of preventable adverse events in elderly patients: population based review of medical records. BMJ 320: 741-744.
11. Green CF, Mottram DR, Rowe PH, Pirmohamed M, (2000) Adverse drug reactions as a cause of admission to an acute medical assessment unit: a pilot study. J Clin Pharm Ther 25: 355-361.
12. Brennan TA, Leape LL, Laird NM, Hebert L, Localio AR, et al. (1991) Incidence of adverse events and negligence in hospitalized patients. Results of the Harvard Medical Practice Study I. The New England journal of medicine 324: 370-376.
13. Leape LL, Brennan TA, Laird N, Lawthers AG, Localio AR, et al. (1991) The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II. The New England journal of medicine 324: 377-384.
14. Lazarou J, Pomeranz BH, Corey PN, (1998) Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 279: 1200-1205.
15. Leape LL, (1994) Error in medicine. JAMA 272: 1851-1857.
16. Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP, (1997) Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA 277: 301-306.
17. Steele L, Fawal H, (2000) 4th Decennial International Conference on nosocomial and healthcare-associated infections: a challenge for change. Am J Infect Control 28: 207-210.
18. Barbaresi WJ, (2003) Use of psychotropic medications in young, preschool children: primum non nocere. Arch Pediatr Adolesc Med 157: 121-123.
19. Ernst E, (2010) Deaths after chiropractic: a review of published cases. International journal of clinical practice 64: 1162-1165.
20. Genuis SJ, (2006) The chemical erosion of human health: adverse environmental exposure and in-utero pollution- determinants of congenital disorders and chronic disease. J Perinat Med 34: 185-195.
21. Centers for Disease Control, Department of Health and Human Services (2009) Fourth National Report on Human Exposure to Environmental Chemicals. 2009. [Accessed Jan 18, 2009] Atlanta: Georgia. 1-529. http://www.cdc.gov/exposurereport/pdf/FourthReport.pdf.
22. Genuis SJ, (2009) Nowhere to hide: Chemical toxicants and the unborn child. Reprod Toxicol 28: 115-116.
23. Gershwin ME, Borchers AT, Keen CL, Hendler S, Hagie F, et al. (2010) Public safety and dietary supplementation. Annals of the New York Academy of Sciences 1190: 104-117.
24. The Canadian Medical Protective Association, (2012) Alternative medicine - What are the medico-legal concerns? P1201-1-E © CMPA 2012: 1-4.
25. Parks LG, Ostby JS, Lambright CR, Abbott BD, Klinefelter GR, et al. (2000) The plasticizer diethylhexyl phthalate induces malformations by decreasing fetal testosterone synthesis during sexual differentiation in the male rat. Toxicological sciences: an official journal of the Society of Toxicology 58: 339-349.
26. Daughton CG, Ternes TA, (1999) Pharmaceuticals and personal care products in the environment: agents of subtle change? Environ Health Perspect 107Suppl 6: 907-938.
27. Darbre PD, (2005) Aluminium, antiperspirants and breast cancer. J Inorg Biochem 99: 1912-1919.
28. Weidenhamer JD, (2009) Lead contamination of inexpensive seasonal and holiday products. Sci Total Environ 407: 2447-2450.
29. Cohen P (2012) Assessing Supplement Safety - The FDA's Controversial Proposal. January 25, 2012 (10.1056/NEJMp1113325.). N Engl J Med.
30. Ernst E, (2000) Prevalence of use of complementary/alternative medicine: a systematic review. Bull World Health Organ 78: 252-257.
31. Thomas KJ, Nicholl JP, Coleman P, (2001) Use and expenditure on complementary medicine in England: a population based survey. Complement Ther Med 9: 2-11.
32. (2005) Baseline Natural Health Products Survey Among Consumers. Health Canada. 85 p.
33. Chaudhuri A, (2005) Why we should offer routine vitamin D supplementation in pregnancy and childhood to prevent multiple sclerosis. Med Hypotheses 64: 608-618.
34. Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, et al. (1998) Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA: the journal of the American Medical Association 280: 1569-1575.
35. Kam PCA, Liew S (2002) Traditional Chinese herbal medicine and anaesthesia. Anaesthesia: Wiley-Blackwell. 1083-1089.
36. Esmail N Complementary and Alternative Medicine in Canada: Trends in Use and Public Attitudes, 1997-2006. The Fraser Institute.
37. Nahin RL, Barnes P.M., Stussman B.J., Bloom B., (2007) Costs of Complementary and Alternative Medicine (CAM) and Frequency of Visits to CAM Practitioners: United States. National health statistics reports. Hyattsville, MD: National Center for Health Statistics.
38. Chiu J, Yau T, Epstein R, (2009) Complications of traditional Chinese/herbal medicines (TCM)-a guide for perplexed oncologists and other cancer caregivers. Supportive Care in Cancer 17: 231-240.
39. Bent S, (2008) Herbal Medicine in the United States: Review of Efficacy, Safety, and Regulation. Journal of General Internal Medicine 23: 854-859.
40. Bates DW, Spell N, Cullen DJ, Burdick E, Laird N, et al. (1997) The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. JAMA 277: 307-311.
41. Phillips DP, Christenfeld N, Glynn LM, (1998) Increase in US medication-error deaths between 1983 and 1993. Lancet 351: 643-644.
42. Kauffman JF, Westenberger BJ, Robertson JD, Guthrie J, Jacobs A, et al. (2007) Lead in pharmaceutical products and dietary supplements. Regulatory Toxicology & Pharmacology 48: 128-134.
43. Jayasundar R Ayurveda: a distinctive approach to health and disease. Current Science (00113891): Indian Academy of Sciences. 908-914.
44. Herron RE, Fagan JB, (2002) Lipophil-mediated reduction of toxicants in humans: an evaluation of an ayurvedic detoxification procedure. Altern Ther Health Med 8: 40-51.
45. Lad V (2003) Ayurveda, A Brief Introduction and Guide. In: Institute TA, editor. Albuquerque.
46. Saper RB, Phillips RS, Sehgal A, Khouri N, Davis RB, et al. (2008) Lead, Mercury, and Arsenic in US- and Indian-Manufactured Ayurvedic Medicines Sold via the Internet. JAMA: The Journal of the American Medical Association 300: 915-923.
47. Sheerin NS, Monk PN, Aslam M, Thurston H, (1994) Simultaneous exposure to lead, arsenic and mercury from Indian ethnic remedies. Br J Clin Pract 48: 332-333.
48. Martena MJ, Van Der Wielen JC, Rietjens IM, Klerx WN, De Groot HN, et al. (2010) Monitoring of mercury, arsenic, and lead in traditional Asian herbal preparations on the Dutch market and estimation of associated risks. Food additives & contaminants Part A, Chemistry, analysis, control, exposure & risk assessment 27: 190-205.
49. Lynch E, Braithwaite R, (2005) A review of the clinical and toxicological aspects of 'traditional' (herbal) medicines adulterated with heavy metals. Expert Opin Drug Saf 4: 769-778.
50. Singh SK, Gautam DN, Kumar M, Rai SB, (2010) Synthesis, characterization and histopathological study of a lead-based Indian traditional drug: naga bhasma. Indian J Pharm Sci 72: 24-30.
51. Wadekar MP, Rode CV, Bendale YN, Patil KR, Prabhune AA, (2005) Preparation and characterization of a copper based Indian traditional drug: tamra bhasma. J Pharm Biomed Anal 39: 951-955.
52. Ernst E, (2002) Toxic heavy metals and undeclared drugs in Asian herbal medicines. Trends in Pharmacological Sciences 23: 136-139.
53. (CDC). CfDCaP (2004) Lead poisoning associated with ayurvedic medications-five states, 2000-2003. MMWR Morb Mortal Wkly Rep 53: 582-584.
54. Karri SK, Saper RB, Kales SN, (2008) Lead Encephalopathy Due to Traditional Medicines. Curr Drug Saf 3: 54-59.
55. van Vonderen MG K-KE, Craanen ME, Touw DJ, Meuwissen SG, De Smet PA, (2000) Severe gastrointestinal symptoms due to lead poisoning from Indian traditional medicine. Am J Gastroenterol 95: 1591-1592.
56. Gair R, (2008) Heavy metal poisoning from Ayurvedic medicines. BCMJ 50: 105.
57. Webb A, Hardikar W, Cranswick NE, Somers GR, (2005) Probable herbal medication induced fulminant hepatic failure. Journal of Paediatrics and Child Health 41: 530-531.
58. Keen RW, Deacon AC, Delves HT, Moreton JA, Frost PG, (1994) Indian herbal remedies for diabetes as a cause of lead poisoning. Postgrad Med J 70: 113-114.
59. Kales SN, Christophi AC, Saper RB, (2007) Hematopoietic toxicity from lead-containing Ayurvedic medications. Med Sci Monitor 13: 295-298.
60. Buettner C MK, Gardiner P, Davis RB, Phillips RS, Mittleman MA, (2009) Herbal supplement use and blood lead levels of United States adults. J Gen Intern Med 24: 1175-1182.
61. Kew J, Morris C, Aihie A, Fysh R, Jones S, Brooks D, (1993) Arsenic and mercury intoxication due to Indian ethnic remedies. BMJ 306: 506-507.
62. Ernst E, (2000) Adverse effects of herbal drugs in dermatology. British Journal of Dermatology 143: 923-929.
63. Khandpur S, Malhotra AK, Bhatia V, Gupta S, Sharma VK, et al. (2008) Chronic arsenic toxicity from Ayurvedic medicines. International Journal of Dermatology 47: 618-621.
64. Pakade YB KA, Singh S, Sharma R, Tewary DK, (2011) Metals in herbal drugs from himalayan region. Bull Environ Contam Toxicol 86: 133-136.
65. Tomlinson B, Chan T, Chan J, Critchley J, But P, (2000) Toxicity of complementary therapies: an eastern perspective. The Journal of Clinical Pharmacology 40: 451-456.
66. Garvey GJ, Hahn G, Lee RV, Harbison RD, (2001) Heavy metal hazards of Asian traditional remedies. Int J Environ Health Res 11: 63-71.
67. Ernst E, (2002) Heavy metals in traditional indian remedies. Eur J Clin Pharmacol 57: 891-896.
68. Ko RJ, (1998) Adulterants in Asian Patent Medicines. New England Journal of Medicine 339: 847-847.
69. Mazzanti G, Battinelli L, Daniele C, Costantini S, Ciaralli L, et al. (2008) Purity control of some Chinese crude herbal drugs marketed in Italy. Food and Chemical Toxicology 46: 3043-3047.
70. Yee SK, Chu SS, Xu YM, Choo PL, (2005) Regulatory control of Chinese Proprietary Medicines in Singapore. Health policy 71: 133-149.
71. Yee S-K, Chu S-S, Xu Y-M, Choo P-L, (2005) Regulatory control of Chinese Proprietary Medicines in Singapore. Health Policy 71: 133-149.
72. Woolf AD, Hussain J, McCullough L, Petranovic M, Chomchai C, (2008) Infantile lead poisoning from an Asian tongue powder: A case report & subsequent public health inquiry. Clinical Toxicology 46: 841-844.
73. (CDC). CfDCaP (1997) Adult lead poisoning from an Asian remedy for menstrual cramps. MMWR Morb Mortal Wkly Rep 48: 27-29.
74. Sallon S, Namdul T, Dolma S, Dorjee P, Dolma D, et al. (2006) Mercury in traditional Tibetan medicine - panacea or problem? Human & Experimental Toxicology: Sage Publications, Ltd. 405-412.
75. Wong SS, Tan KC, Goh CL, (1998) Cutaneous manifestations of chronic arsenicism: Review of seventeen cases. Journal of the American Academy of Dermatology 38: 179-185.
76. Cheng S, (2003) Heavy metal pollution in China: origin, pattern and control. Environ Sci Pollut Res Int 10: 192-198.
77. Cheng S, (2003) Heavy metals in plants and phytoremediation. Environ Sci Pollut Res Int 10: 335-340.
78. Fu J ZQ, Liu J, Liu W, Wang T, Zhang Q, Jiang G, (2008) High levels of heavy metals in rice (Oryza sativa L.) from a typical E-waste recycling area in southeast China and its potential risk to human health. Chemosphere 71: 1269-1275.
79. Cao H CJ, Zhang J, Zhang H, Qiao L, Men Y, (2010) Heavy metals in rice and garden vegetables and their potential health risks to inhabitants in the vicinity of an industrial zone in Jiangsu, China. J Environ Sci (China) 22: 1792-1799.
80. Wong M, Tan P, Wee Y, (1993) Heavy metals in some Chinese herbal plants. Biological Trace Element Research 36: 135-142.
81. Chan K, (2003) Some aspects of toxic contaminants in herbal medicines. Chemosphere 52: 1361-1371.
82. (2010) About Natural Health Product Regulation in Canada. Health Canada.
83. U. S. Department of Health and Human Services: Food and Drug Administration (2011) Draft Guidance for Industry: Dietary Supplements: New Dietary Ingredient Notifications and Related Issues. Accssed August 15, 2011 at [http://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/DietarySupplements/ucm257563.htm].
84. U.S. Department of Health and Human Services: Food and Drug Administration (2010) Guidance for Industry: Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements; Small Entity Compliance Guide. Accesses Aug 15,2011 at [http://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/SmallBusinessesSmallEntityComplianceGuides/ucm238182.htm].
85. California's safe drinking water and toxic enforcement act of 1986 (2003) Dietary Supplement Standard 173, Metal Contaminant Acceptance Levels NSF International, August 19,2003 Accessed on Jan 22/2012 at [http://www.nsf.org/business/newsroom/pdf/DS_Metal_Contaminant_Acceptance_Levels.pdf].
86. Ren A, Qiu X, Jin L, Ma J, Li Z, et al. (2011) Association of selected persistent organic pollutants in the placenta with the risk of neural tube defects. Proceedings of the National Academy of Sciences of the United States of America 108: 12770-12775.
87. Campbell M, Petti TA, Green WH, Cohen IL, Genieser NB, et al. (1980) Some physical parameters of young autistic children. Journal of the American Academy of Child Psychiatry 19: 193-212.
88. Bernhoft RA, (2012) Mercury toxicity and treatment: a review of the literature. Journal of environmental and public health 2012: 460508.
89. Becaria A, Campbell A, Bondy SC, (2002) Aluminum as a toxicant. Toxicol Ind Health 18: 309-320.
90. Bellinger DC, (2008) Very low lead exposures and children's neurodevelopment. Curr Opin Pediatr 20: 172-177.
91. Agency for Toxic Substances Disease Registry (2008) Toxicological profile of Cadmium.
92. Genuis SJ, Birkholz D, Rodushkin I, Beesoon S, (2011) Blood, urine, and sweat (BUS) study: monitoring and elimination of bioaccumulated toxic elements. Archives of environmental contamination and toxicology 61: 344-357.
93. Environmental Working Group (2009) Polluton in people: cord blood contaminants in minority newborns. Accessed Sept 6/2011 at http://www.ewg.org/files/2009-Minority-Cord-Blood-Report.pdf 3-60.
94. Centers for Disease Control USDfHaHS, Public Health Service, Agency for Toxic Substances and Disease Registry, Dvision of Toxicology. (2001) Agency for Toxic Substances and Disease Registry: Interaction Profiles for Toxic Substances. Accessed Jan 22, 2012 at [http://www.atsdr.cdc.gov/interactionprofiles/index.asp].
95. Stamova B, Green PG, Tian Y, Hertz-Picciotto I, Pessah IN, et al. (2011) Correlations between gene expression and mercury levels in blood of boys with and without autism. Neurotoxicity research 19: 31-48.
96. Tian Y, Green PG, Stamova B, Hertz-Picciotto I, Pessah IN, et al. (2011) Correlations of gene expression with blood lead levels in children with autism compared to typically developing controls. Neurotoxicity research 19: 1-13.
97. United Nations Environment Programme C Lead exposure and human health. Accessed Jan20/2012 at [http://www.chem.unep.ch/pops/pdf/lead/leadexp.pdf]. Geneva, Switzerland.
98. Rat Genome Sequencing Project C (2004) Genome sequence of the Brown Norway rat yields insights into mammalian evolution. Nature 428: 493-521.
99. MacDonald NE, MacLeod S, Stanbrook MB, Hebert PC, Flegel K, et al. (2011) No regulatory double standard for natural health products. CMAJ: Canadian Medical Association journal = journal de l'Association medicale canadienne 183: 2079.
100. National Institutes of Health (2011) InfoFacts: Drug-Related Hospital Emergency Room Visits. Accessed Jan 30,2011 at [http://www.drugabuse.gov/publications/infofacts/drug-related-hospital-emergency-room-visits].
101. Lo C, (2000) Integrating nutrition as a theme throughout the medical school curriculum. Am J Clin Nutr 72: 882S-889S.
102. United States Environmental Protection Agency Integrated risk information system. EPA/635/R-05/001. Accessed January 22/2012 at [www.epa.gov/iris].
103. World Health Organization - Europe. European environment and health information system (2009) Exposure of children to chemical hazards in food. Fact sheet 4.4. Accessed on Jan 22/2012 at [. http://www.euro.who.int/__data/assets/pdf_file/0004/97042/4.4.-Exposure-of-children-to-chemical-hazards-in-food-EDITED_layouted.pdf].
104. European Food Safety Authority (2008) Safety of aluminium from dietary intake[1]- Scientific Opinion of the Panel on Food Additives, Flavourings, Processing Aids and Food Contact Materials (AFC) Accessed on January 22/2012 at [http://www.efsa.europa.eu/en/efsajournal/pub/754.htm].
105. European Food Safety Authority, (2004) Opinion of the Scientific Panel on food additives, flavourings, processing aids and materials in contact with food (AFC) on a request from the Commission related to a 2nd list of substances for food contact materials. The EFSA Journal 24: 1-13.
106. Food standards Australia New Zealand (2011) The 23rd Australian Total Diet Study. Accessed on January 22/2012 at [http://www.foodstandards.gov.au/_srcfiles/FSANZ%2023rd%20ATDS_v5.pdf].
107. European Food Safety Authority (2004) Opinion of the Scientific Panel on contaminants in the food chain [CONTAM] related to mercury and methylmercury in food. Accessed on January 22/2012 at [http://www.efsa.europa.eu/en/efsajournal/pub/34.htm] doi:10.2903/j.efsa.2004.34.
108. European Food Safety Authority (2010) Scientific Opinion on Lead in Food. EFSA Journal 2010; 8(4): 1570 [147 pp.] doi:10.2903/j.efsa.2010.1570.
109. Saper RB, Kales SN, Paquin J, Burns MJ, Eisenberg DM, et al. (2004) Heavy metal content of ayurvedic herbal medicine products. JAMA 292: 2868-2873.
110. Saper RB, Phillips RS, Sehgal A, Khouri N, Davis RB, et al. (2008) Lead, mercury, and arsenic in US- and Indian-manufactured Ayurvedic medicines sold via the Internet. JAMA: the journal of the American Medical Association 300: 915-923.
111. Koh HL, Woo SO, (2000) Chinese proprietary medicine in Singapore: regulatory control of toxic heavy metals and undeclared drugs. Drug safety: an international journal of medical toxicology and drug experience 23: 351-362.
112. Pakade YB, Kumari A, Singh S, Sharma R, Tewary DK, (2011) Metals in herbal drugs from Himalayan region. Bull Environ Contam Toxicol 86: 133-136.
113. Harris ES, Cao S, Littlefield BA, Craycroft JA, Scholten R, et al. (2011) Heavy metal and pesticide content in commonly prescribed individual raw Chinese Herbal Medicines. Sci Total Environ 409: 4297-4305.
114. Singh R Toxic metal analysis in ayurvedic drug systems. XXXII National Systems Conference, NSC 2008 Dec 17-19, 2008pp 664-666.